CD44 and cancer: qRT‒PCR and flow cytometry were conducted to assess the expression of the cancer stem cell marker CD44.<h4>Results</h4>HMPSNE enhanced the cytotoxic, anticlonogenic and antimigratory effects of doxorubicin on MDA-MB-231 cells.